Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2991 studies found for:    cyclophosphamide
Show Display Options
Rank Status Study
1 Active, not recruiting Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy
Condition: Hematologic Malignancies
Intervention: Drug: Cyclophosphamide
2 Completed
Has Results
High Dose Cyclophosphamide for Treatment of Scleroderma
Condition: Scleroderma
Intervention: Drug: IV Cyclophosphamide
3 Recruiting High-dose Cyclophosphamide for Severe Refractory Crohn Disease
Conditions: Crohn's Disease;   Crohn Disease
Intervention: Drug: High-dose Cyclophosphamide
4 Recruiting A Trial of Dasatinib (PDGFR and SRC Inhibitor), Temsirolimus and Cyclophosphamide in Patients With Advanced Solid Tumors
Condition: Solid Tumors
Interventions: Drug: Dasatinib;   Drug: Cyclophosphamide;   Drug: Temsirolimus
5 Active, not recruiting Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants
Condition: Antibody Mediated Rejection
Intervention: Drug: Cyclophosphamide
6 Unknown  Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
Condition: Pemphigus
Intervention: Drug: Rituximab and Cyclophosphamide IV
7 Active, not recruiting Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS)
Conditions: Chronic Fatigue Syndrome (CFS);   Myalgic Encephalomyelitis (ME)
Intervention: Drug: Cyclophosphamide
8 Completed
Has Results
Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients
Conditions: Burkitt's Lymphoma;   Lymphoblastic Lymphoma;   Acute Lymphoblastic Leukemia
Interventions: Drug: Clofarabine;   Drug: Cyclophosphamide
9 Unknown  Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: cyclophosphamide,cyclosporine A
10 Unknown  Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)
Condition: Amyloidosis
Intervention: Drug: Lenalidomide, Dexamethasone and Cyclophosphamide
11 Recruiting Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors
Conditions: Recurrent or Refractory Solid Tumors;   Ewing Sarcoma;   Rhabdomyosarcoma;   Neuroblastoma;   Osteosarcoma
Intervention: Drug: MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
12 Completed CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma
Condition: Melanoma
Intervention: Drug: Cyclophosphamide, Ipilimumab
13 Completed Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
Conditions: SLE;   Lupus Nephritis;   Renal Insufficiency;   End-stage Renal Disease
Interventions: Drug: Tacrolimus;   Drug: cyclophosphamide
14 Active, not recruiting Cyclophosphamide for Nasopharyngeal Carcinoma
Conditions: Recurrent Nasopharyngeal Undifferentiated Carcinoma;   Stage IV Nasopharyngeal Undifferentiated Carcinoma
Intervention: Drug: Cyclophosphamide
15 Completed Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies
Condition: Lung Cancer
Interventions: Drug: Amrubicin;   Drug: Cyclophosphamide
16 Recruiting Treatment of Rapid Onset Obesity, Hypoventilation, Hypothalamic Dysfunction, and Autonomic Dysregulation (ROHHAD )
Condition: ROHHAD Syndrome
Intervention: Drug: Cyclophosphamide
17 Completed
Has Results
Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Etoposide;   Drug: Cyclophosphamide
18 Completed Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: sorafenib and cyclophosphamide
19 Recruiting Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
Conditions: Conventional Chondrosarcoma;   Myxoid Liposarcoma;   Mesenchymal Chondrosarcoma;   Dedifferentiated Chondrosarcoma
Intervention: Drug: sirolimus and cyclophosphamide
20 Recruiting Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies
Conditions: Malignant Solid Tumour;   Breast Cancer Nos Metastatic Recurrent;   Neuropathy
Intervention: Drug: Eribulin in Combination w/ Cyclophosphamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.